(Q72682240)
Statements
Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point (English)
A Decensi
S Bruno
A Curotto
B Gatteschi
G Nicolò
A Polizzi
M Perloff
1 January 1994